![]() | Up a level |
Journal Article
Heesterbeek, Thomas J., Lechanteur, Yara T. E., Lores-Motta, Laura, Schick, Tina, Daha, Mohamed R., Altay, Lebriz, Liakopoulos, Sandra, Smailhodzic, Dzenita, den Hollander, Anneke, I, Hoyng, Carel B., de Jong, Eiko K. and Klevering, B. Jeroen (2020). Complement Activation Levels Are Related to Disease Stage in AMD. Invest. Ophthalmol. Vis. Sci., 61 (3). ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783
Hermann, Manuel M., van Asten, Freekje ORCID: 0000-0002-8141-4234, Muether, Philipp S., Smailhodzic, Dzenita, Lichtner, Peter, Hoyng, Carel B., Kirchhof, Bernd, Grefkes, Christian
ORCID: 0000-0002-1656-720X, den Hollander, Anneke I. and Fauser, Sascha
(2014).
Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular Degeneration.
Ophthalmology, 121 (4).
S. 905 - 911.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1549-4713
Lores-Motta, Laura ORCID: 0000-0002-2423-9126, van Asten, Freekje
ORCID: 0000-0002-8141-4234, Muether, Philipp S., Smailhodzic, Dzenita, Groenewoud, Joannes M., Omar, Amer
ORCID: 0000-0003-1520-392X, Chen, John, Koenekoop, Robert K., Fauser, Sascha, Hoyng, Carel B., den Hollander, Anneke I. and de Jong, Eiko K.
(2016).
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.
Pharmacogenet. Genomics, 26 (1).
S. 20 - 28.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1744-6880
Riaz, Moeen, Lores-Motta, Laura ORCID: 0000-0002-2423-9126, Richardson, Andrea J., Lu, Yi
ORCID: 0000-0001-9933-3654, Montgomery, Grant, Omar, Amer
ORCID: 0000-0003-1520-392X, Koenekoop, Robert K., Chen, John, Muether, Philipp, Altay, Lebriz, Schick, Tina, Fauser, Sascha, Smailhodzic, Dzenita, van Asten, Freekje
ORCID: 0000-0002-8141-4234, de Jong, Eiko K., Hoyng, Carel B., Burdon, Kathryn P., MacGregor, Stuart, Guymer, Robyn H., den Hollander, Anneke I. and Baird, Paul N.
(2016).
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.
Sci Rep, 6.
LONDON:
NATURE PUBLISHING GROUP.
ISSN 2045-2322
Smailhodzic, Dzenita, Muether, Philipp S., Chen, John, Kwestro, Angela, Zhang, Alice Yang ORCID: 0000-0001-5194-5256, Omar, Amer
ORCID: 0000-0003-1520-392X, Van de Ven, Johannes P. H., Keunen, Jan E. E., Kirchhof, Bernd, Hoyng, Carel B., Klevering, B. Jeroen, Koenekoop, Robert K., Fauser, Sascha and den Hollander, Anneke I.
(2012).
Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration.
Ophthalmology, 119 (11).
S. 2304 - 2312.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1549-4713
Smailhodzic, Dzenita, van Asten, Freekje ORCID: 0000-0002-8141-4234, Blom, Anna M., Mohlin, Frida C., den Hollander, Anneke I., van de Ven, Johannes P. H., van Huet, Ramon A. C., Groenewoud, Joannes M. M., Tian, Yuan, Berendschot, Tos T. J. M., Lechanteur, Yara T. E., Fauser, Sascha, de Bruijn, Chris, Daha, Mohamed R., van der Wilt, Gert Jan, Hoyng, Carel B. and Klevering, B. Jeroen
(2014).
Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration.
PLoS One, 9 (11).
SAN FRANCISCO:
PUBLIC LIBRARY SCIENCE.
ISSN 1932-6203
de Motta, Laura Lores, Van Asten, Freekje, Muether, Philipp S., Smailhodzic, Dzenita, Chen, John C., Koenekoop, Robert K., Fauser, Sascha, Hoyng, Carel C. B., Den Hollander, Anneke I. and de Jong, Eiko (2015). A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 56 (7). ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783
van Asten, Freekje ORCID: 0000-0002-8141-4234, Rovers, Maroeska M., Lechanteur, Yara T. E., Smailhodzic, Dzenita, Muether, Philipp S., Chen, John, den Hollander, Anneke I., Fauser, Sascha, Hoyng, Carel B., van der Wilt, Gert Jan
ORCID: 0000-0002-5856-762X and Klevering, B. Jeroen
(2014).
Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration.
Ophthalmic Epidemiol., 21 (6).
S. 347 - 356.
PHILADELPHIA:
TAYLOR & FRANCIS INC.
ISSN 1744-5086